Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

2,025.27
-21.4641-1.05%
Number of Gainers:3
Number of Losers:7
Number of Flat:1
PE:- -
High:2,049.23
Open:2,046.69
Low:2,023.95
Close:2,046.76
Volume:3.06M
Turnover:131.86M
Market Cap:224.16B
Float Cap:223.46B

Loading ...

Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer

THOMSON REUTERS
·
Sep 08

Virax Biolabs Enters At-the-Market Offering Agreement for Ordinary Share Sales

Reuters
·
Sep 05

Quest Diagnostics CEO James E. Davis Sells 10,000 Shares Worth $2.43 Million

Reuters
·
Sep 04

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 04

Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst

TIPRANKS
·
Sep 04

Tonix Highlights Tonmya Fibromyalgia Launch, Pipeline Progress in Investor Presentation

Reuters
·
Sep 03

Emergent BioSolutions Repurchases $75 Million of Senior Unsecured Notes Due 2028

MT Newswires Live
·
Sep 03

Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes

THOMSON REUTERS
·
Sep 03

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares

Reuters
·
Sep 03

Emergent BioSolutions Secures New BARDA Anthrax Contract

TIPRANKS
·
Sep 02

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 02

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

Dow Jones
·
Sep 02

Emergent BioSolutions: Got Contract Modification of Barda Av7909 Contract from Office of Assistant Secretary for Preparedness and Response

THOMSON REUTERS
·
Sep 02

Emergent BioSolutions - Contract Modification for Procurement of Additional Cyfendus (Av7909) Doses - SEC Filing

THOMSON REUTERS
·
Sep 02

Inovio to Present at Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Sep 02

Emergent BioSolutions Wins $24 Million BARDA Contract Modification for Cyfendus Anthrax Vaccine Supply

Reuters
·
Sep 01

Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted)

THOMSON REUTERS
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01